A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer Conference Paper uri icon

authors

  • Lickliter, J
  • Gan, H
  • Gao, B
  • Grimison, P
  • Zou, J
  • Kallender, H
  • Sun, K
  • Chen, X
  • Behren, A
  • Fernandez-Penas, P
  • Nagrial, A
  • Voskoboynik, M
  • Woods, K
  • Millward, M
  • Meniawy, T

publication date

  • September 1, 2017